# Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

> **NCT03841058** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Hospital for Special Surgery, New York** · enrollment: 96 (estimated)

## Conditions studied

- Spinal Fusion

## Interventions

- **DRUG:** Abaloparatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03841058
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-08-14
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03841058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03841058, "Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03841058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*